{"nct_id":"NCT03978611","title":"A Study to Assess Safety of Relatlimab With Ipilimumab in Participants With Advanced Melanoma Who Progressed on Anti-Programmed Cell Death Protein 1 (Anti-PD-1) Treatment","status":"TERMINATED","status_verified_date":"2024-07","start_date":"2021-12-09","start_date_type":"ACTUAL","primary_completion_date":"2023-07-26","primary_completion_date_type":"ACTUAL","completion_date":"2023-07-26","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["BMY"]}